Business Wire requests that the press release NewsItemId: 20220929005273 "Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC" be removed. Business Wire 888-381-9473
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has made a capital investment in Diabetes Reversal Group, LLC. “Cerebain is happy to announce it has made a capital investment in Diabetes Reversal Group, LLC...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership of PKG, Inc. About Cerebain Biotech Corp. Cerebain Bi...
Cerebain Biotech Corp. (OTC: CBBT) (the “Company” or “Cerebain”) today provided an update pertaining to the Share Exchange Agreement with PKG, Inc., an Idaho Corporation (PKG) and the equity holders of PKG. Pursuant to the Share Exchange Agreement, signed...
Cerebain Biotech Corp. (OTC: CBBT), today announced that PKG, Inc. is to become the key manufacturer for ClearMask, LLC and Xometry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201125005429/en/ See the person...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announces a General Business Update. Cerebain is in the final stages of its acquisition of PKG, Inc. In combination with the closing of the acquisition of PKG, Cerebain intends to bri...
BEVERLY HILLS, CA / ACCESSWIRE / October 6, 2020 / NMS Consulting, Inc. ("NMS") is pleased to announce that it has been selected as strategic advisor by Cerebain Biotech Cop . (OTCPINK:CBBT) ("Cerebain") for its planned acquisition of PKG, Inc. ("PKG"). As part of the initial scope of ...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) previously announced, on August 25, 2020, that it had entered into a Letter of Intent to purchase the assets of PKG, Inc. (PKG). Almir Garibovic, CEO of PKG Inc., stated “After 30 years in...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has entered into a Letter of Intent to purchase the assets of PKG, Inc. (PKG). PKG, Inc. was established in 1989 and is a privately held corporation based out of Meridian,...
News, Short Squeeze, Breakout and More Instantly...
Cerebain Biotech Corp Com Company Name:
CBBT Stock Symbol:
OTCMKTS Market:
Business Wire requests that the press release NewsItemId: 20220929005273 "Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC" be removed. Business Wire 888-381-9473
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has made a capital investment in Diabetes Reversal Group, LLC. “Cerebain is happy to announce it has made a capital investment in Diabetes Reversal Group, LLC...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership of PKG, Inc. About Cerebain Biotech Corp. Cerebain Bi...